Breaking News Instant updates and real-time market news.

BA

Boeing

$319.61

-17.49 (-5.19%)

, PH

Parker-Hannifin

$175.87

-5.88 (-3.24%)

04:55
03/23/18
03/23
04:55
03/23/18
04:55

BofA/Merrill to hold a conference

Global Industrials Conference will be held in London, England on March 20-23.

BA

Boeing

$319.61

-17.49 (-5.19%)

PH

Parker-Hannifin

$175.87

-5.88 (-3.24%)

TKR

Timken

$45.85

-2.15 (-4.48%)

CAT

Caterpillar

$146.90

-8.9 (-5.71%)

AGCO

Agco

$62.88

-2.99 (-4.54%)

ALSN

Allison Transmission

$37.97

-1.31 (-3.34%)

KSU

Kansas City Southern

$108.31

-1.55 (-1.41%)

IR

Ingersoll-Rand

$86.08

-2.91 (-3.27%)

HON

Honeywell

$146.88

-4.48 (-2.96%)

ROK

Rockwell Automation

$175.96

-5.42 (-2.99%)

KMT

Kennametal

$41.50

-2.19 (-5.01%)

FTV

Fortive

$76.69

-1.66 (-2.12%)

MMM

3M

$223.17

-10.97 (-4.69%)

ALLE

Allegion

$84.60

-1.34 (-1.56%)

  • 26

    Mar

  • 28

    Mar

  • 16

    Apr

  • 02

    May

  • 03

    May

  • 10

    May

  • 30

    May

  • 13

    Jun

  • 25

    Jun

BA Boeing
$319.61

-17.49 (-5.19%)

02/13/18
EDJN
02/13/18
UPGRADE
EDJN
Buy
Boeing upgraded to Buy from Hold at Edward Jones
02/13/18
02/13/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. JPMorgan (JPM) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Brian Kleinhanzl saying he views the recent pullback in the shares as a buying opportunity. 2. Total (TOT) upgraded to Overweight from Equal Weight at Morgan Stanley and to Strong Buy from Outperform at Raymond James. 3. Celgene (CELG) upgraded to Overweight from Equal Weight at Barclays with analyst Geoff Meacham saying the current valuation largely reflects the risk. 4. Quest Diagnostics (DGX) upgraded to Outperform from Neutral at Credit Suisse with analyst A.J. Rice saying he believes the company has "substantial runway on several fronts," including its Optum partnership related to revenue cycle management, which he believes could reduce bad debts and claims denials. 5. Boeing (BA) upgraded to Buy from Hold at Edward Jones. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/13/18
JEFF
03/13/18
NO CHANGE
Target $400
JEFF
Buy
Boeing booked 21 widebody orders in February, says Jefferies
Jefferies analyst Sheila Kahyaoglu says the most incremental item in Boeing's February orders report was the booking of 21 widebody orders, including three legacy 777s. The company is adding to its widebody backlog, Kahyaoglu tells investors in a research note. She notes that at current production rates, on average Boeing has more than seven years of production in backlog. The analyst sees support for upcoming rate increases and keeps a Buy rating on Boeing shares with a $400 price target.
03/14/18
JPMS
03/14/18
NO CHANGE
JPMS
Spirit AeroSystems, Boeing weakness appears overdone, says JPMorgan
JPMorgan analyst Seth Seifman said he is not surprised that Spirit AeroSystems (SPR) would underperform after the company made comments at the firm's Aviation, Transportation and Industrials Conference about 737 cost pressure in Q1. He also believes the decline in the stock, as well as in shares of Boeing (BA), appears overdone. He thinks Spirit is "taking a hit" now so that it can meet its commitments to Boeing, noting that the company has maintained its earnings outlook for the year and has a history of conservatism. Seifman added that he does not think this morning's 737 MAX news is the only factor weighing on Boeing and Spirit, however, as reports that President Trump is considering $60B of tariffs on Chinese goods are "likely not helping," but he still thinks a rupture in Boeing's relationship with China is unlikely.
PH Parker-Hannifin
$175.87

-5.88 (-3.24%)

03/08/18
KEYB
03/08/18
NO CHANGE
Target $225
KEYB
Overweight
Parker-Hannifin should be bought 'aggressively' on pullback, says KeyBanc
KeyBanc analyst Jeffrey Hammond says he would be an "aggressive" buyer of Parker-Hannifin on a pullback as the company's Analyst Day reinforced its compelling long-term story. The analyst believes incremental margins should snap back near-term, and the long-term organic growth, margin expansion, and capital allocation opportunities support compelling earnings and cash flow growth over time. Hammond reiterates an Overweight rating and $225 price target on the shares.
03/08/18
BARD
03/08/18
UPGRADE
BARD
Outperform
Parker-Hannifin upgraded to Outperform from Neutral at Baird
03/08/18
BARD
03/08/18
UPGRADE
Target $203
BARD
Outperform
Parker-Hannifin upgraded to Outperform at Baird
As reported previously, Baird analyst Mig Dobre upgraded Parker-Hannifin to Outperform from Neutral. The analyst cited management's investor day meeting where they put forth a credible path to at least $15 of earnings per share by 2023, the company's clear internal execution momentum, and the benefits from continued business and cost structure simplification. Dobre maintained his $203 price target on Parker-Hannifin shares.
01/19/18
01/19/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Zillow (Z, ZG) resumed with a Hold from Buy at Stifel with analyst John Egbert saying he sees potential macro headwinds for Zillow given the tight housing supply, rising interest rates, and tax changes. 2. Bloomin' Brands (BLMN) downgraded to Sell from Neutral at Goldman Sachs with analyst Karen Holthouse saying shares are trading near peak historical levels versus peers and "thin pre-tax margins" put the company at risk of estimate volatility around investment. 3. Parker-Hannifin (PH) downgraded to Neutral on valuation at Buckingham with the firm's analyst saying shares reached the firm's $210 price target. 4. McCormick (MKC) downgraded to Sell from Hold at Deutsche Bank with analyst Rob Dickerson saying he believes organic revenue growth expectations in the company's Consumer segment for fiscal years 2018 and 2019 are too high. 5. WNS Holdings (WNS) downgraded to Neutral from Outperform at Baird with analyst David Koning citing its high historical valuation but saying he sees fourth quarter revenues decelerating, which could create a headwind as comps become more difficult. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
TKR Timken
$45.85

-2.15 (-4.48%)

08/07/17
GSCO
08/07/17
DOWNGRADE
Target $51
GSCO
Buy
Timken downgraded to Buy from Conviction Buy at Goldman Sachs
Goldman Sachs analyst Samuel Eisner removed Timken from the Conviction Buy List after Q2 operating leverage missed his expectations and reduced his confidence. The analyst said he underestimated incentive comp and increased costs associated with accelerated sales growth but remains Buy rated on upside to valuation given his forecast for higher CoC earnings.
01/18/18
JEFF
01/18/18
UPGRADE
Target $63
JEFF
Buy
Timken upgraded to Buy from Hold at Jefferies
Jefferies analyst Stephen Volkman upgraded Timken to Buy and raised his price target for the shares to $63 from $50. The analyst's analysis suggests the "modest" mid-single digit organic growth being baked into 2018 consensus estimates for the company is conservative. Most of Timken's end markets continue to trend positively, even rail, which has been a drag through 2017, Volkman tells investors in a research note.
01/02/18
LBOW
01/02/18
UPGRADE
LBOW
Buy
Timken upgraded to Buy from Neutral at Longbow
CAT Caterpillar
$146.90

-8.9 (-5.71%)

03/02/18
03/02/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Home Depot (HD), Lowe's (LOW), Tempur Sealy (TPX), Mohawk (MHK), Lumber Liquidators (LL) and Michaels (MIK) initiated with a Hold at Loop Capital. The firm also started Fortune Brands (FBHS) and Wayfair (W) with a Buy. 2. Aflac (AFL), Lincoln National (LNC), Brighthouse Financial (BHF), MetLife (MET) Unum (UNM), Principal Financial (PFG) and Reinsurance Group (RGA) initiated with a Neutral at UBS. The firm also initiated Voya (VOYA) and FGL Holdings (FG) with a Buy and Torchmark (TMK) and American Equity (AEL) with a Sell. 3. HP Enterprise (HPE) initiated with a Neutral at JPMorgan. 4. Caterpillar (CAT), Deere (DE), United Rentals (URI) and Wabco (WBC) initiated with an Overweight, Oshkosh (OSK), Terex (TEX), Cummins (CMI), CNH Industrial (CNHI) and REV Group (REVG) initiated with an Equal Weight and Paccar (PCAR) and Agco (AGCO) initiated with an Underweight at Morgan Stanley. 5. Conatus (CNAT) initiated with an Outperform at Oppenheimer. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/15/18
UBSW
02/15/18
NO CHANGE
Target $190
UBSW
Buy
Competition analysis solidifies Caterpillar's market leadership, says UBS
UBS analyst Steven Fisher said an analysis of the construction equipment market shows that Caterpillar is by far the market leader. They have the highest capacity share, the best market quality, and low competitive overlap, said Fisher, who reiterated his Buy rating and $190 price target on Caterpillar shares.
02/01/18
ARGS
02/01/18
NO CHANGE
Target $185
ARGS
Buy
Caterpillar price target raised to $185 from $155 at Argus
Argus analyst John Eade raised his price target on Caterpillar to $185 and kept his Buy rating, saying the management was optimistic about the outlook in its latest earnings report. Eade raises his FY18 EPS target to $9.20 from $8.30, forecasts more growth in FY19, and adds that shares continue to offer value despite the recent advance in the stock price. The analyst believes that various commodity and currency trends are turning in the company's favor, just as the management takes steps to aggressively reduce costs.
03/02/18
MSCO
03/02/18
INITIATION
Target $185
MSCO
Overweight
Caterpillar initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst Courtney Yakavonis initiated coverage of the Construction Machinery space, starting Caterpillar with an Overweight rating and $185 price target. Construction machinery stocks have outperformed since 2016, but a recovery in the global economy and key end markets leads Yakavonis to believe that there could be further to go, she tells investors. The firm's most recent dealer survey indicates points to inventories having been "right-sized" compared to 2016 and Caterpillar's strong top line momentum, further margin expansion opportunities, and attractive valuation make it her top pick in the space, she said.
AGCO Agco
$62.88

-2.99 (-4.54%)

02/08/18
BMOC
02/08/18
NO CHANGE
Target $75
BMOC
Market Perform
Agco price target lowered to $75 from $85 at BMO Capital
BMO Capital analyst Joel Tiss lowered his price target on AGCO to $75 and kept his Market Perform rating after a stock price decline following Q4 results. Tiss says that the stock underperformance was an overreaction, as the company has been "rolling out new offerings and innovations to help increase market share and position it for a stronger recovery". The analyst also attributes the soft margins to weakness in South America from lower production caused by an inventory pre-build in year-ago quarter.
03/02/18
MSCO
03/02/18
INITIATION
Target $69
MSCO
Underweight
Agco initiated with an Underweight at Morgan Stanley
Morgan Stanley analyst Courtney Yakavonis initiated coverage of the Agricultural Machinery space, starting Agco with an Underweight rating and $69 price target given its outsized exposure to the less robust European replacement cycle as well as its dairy and sugar exposure.
02/07/18
JPMS
02/07/18
UPGRADE
Target $66
JPMS
Neutral
Agco upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Ann Duignan upgraded Agco to Neutral with an unchanged price target of $66. The analyst believes the risk/reward is more "evenly balanced" at current valuation levels with the stock down 5.8% year-to-date.
ALSN Allison Transmission
$37.97

-1.31 (-3.34%)

02/16/18
STFL
02/16/18
UPGRADE
Target $50
STFL
Buy
Allison Transmission upgraded to Buy after pullback at Stifel
Stifel analyst Michael Baudendistel upgraded Allison Transmission to Buy and raised his price target for the shares to $50 from $44. JPMorgan this morning downgraded the shares to Underweight. Following the post-earnings selloff, the company's cash flow outlook is "too strong to ignore," Baudendistel tells investors in a research note. The analyst believes Allison 's set-up into 2018 remains favorable, with further production growth expected in core markets.
02/16/18
RBCM
02/16/18
DOWNGRADE
Target $46
RBCM
Sector Perform
Allison Transmission cut to Sector Perform at RBC Capital on limited catalysts
As reported earlier, RBC Capital analyst Scott Weber downgraded Allison Transmission to Sector Perform from Outperform and lowered his price target to $46 from $50, citing a mixed Q4 earnings report and FY18 outlook. The analyst contends that while the company tends to guide conservatively and its 10% free cash flow yield makes it an "attractive" long term holding, he sees few potential upside catalysts and a potential for flattening margins.
03/05/18
JPMS
03/05/18
NO CHANGE
JPMS
U.S. indicators for truck purchases still trending positively, says JPMorgan
JPMorgan analyst Ann Duignan noted that ACT Research released preliminary truck orders for February that showed Class 8 net orders of 40,600 units, up 75% year-over-year and down 17% month-over-month from January's twelve-year high. The analyst, who noted that February's Class 5-8 order volume represents the fifth best reading since 2000, stated that U.S. macro indicators for truck purchases have continued to trend positively. She pointed to Navistar (NAV), Paccar (PCAR), Cummins (CMI), Eaton (ETN) and Allison Transmission (ALSN) as the stocks she covers on which truck orders have the largest incremental impact.
02/16/18
02/16/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Biogen (BIIB) downgraded to Hold from Buy at Argus with analyst David Toung citing increased competition for the company's multiple sclerosis drugs, anticipating related sales to slow from the fourth quarter when results were boosted by "one-time factors." 2. Omnicom (OMC) downgraded to Sector Perform from Outperform at RBC Capital with analyst Steven Cahall downgraded Omnicom (OMC) to Sector Perform from Outperform and lowered his price target to $83 from $87. Cahall says the weaker than expected Q4 organic growth and soft FY18 outlook demonstrates the "opacity facing the industry". The analyst adds that he was hopeful to see more visibility into earnings growth by now. 3. Allison Transmission (ALSN) was downgraded to Sector Perform at RBC Capital and to Underweight from Neutral at JPMorgan. 4. Dr Pepper Snapple (DPS) downgraded to Hold from Buy at Jefferies with analyst Kevin Grundy saying the post-merger guidance "leaves little room for error" and the competitive environment in beverages is likely to "heat up." 5. Kimco Realty (KIM) downgraded to Neutral from Buy at BofA/Merrill with analyst Craig Schmidt saying he came away from earnings cautious on Kimco's weaker 2018 same-store NOI growth outlook of 1.25%-2%, the midpoint being the lowest since the recession, and 300M share repurchase program given the company's already high leverage and need to fund developments. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
KSU Kansas City Southern
$108.31

-1.55 (-1.41%)

03/08/18
FBCO
03/08/18
NO CHANGE
Target $121
FBCO
Outperform
Kansas City Southern price target lowered to $121 from $126 at Credit Suisse
Credit Suisse analyst Allison Landry lowered her price target for Kansas City Southern to $121 from $126 to reflect lower base year EBIT and a higher discount rate in her DCF model. The analyst reiterates an Outperform rating on the shares.
01/16/18
SUSQ
01/16/18
NO CHANGE
SUSQ
Rail stocks cheaper than they appear, says Susquehanna
Susquehanna analyst Bascome Majors said he likes the rails into 2018, citing the potential for volume-led revisions and possible inflection in free cash flow. He sees the rails as well positioned from multiple cyclical tailwinds, including improved outlooks for core industrial and consumer markets, inflationary pricing, a capacity constrained truckload environment, and a federal infrastructure package that could potentially drive incremental demand. Majors likes CSX (CSX), Union Pacific (UNP), Norfolk Southern (NSC) and Genesee & Wyoming (GWR) shares.
12/04/17
BOFA
12/04/17
NO CHANGE
BOFA
Buy
Kansas City Southern added to US 1 List at BofA/Merrill
11/13/17
GSCO
11/13/17
INITIATION
Target $109
GSCO
Neutral
Kansas City Southern initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Matt Reustle initiated Kansas City Southern with a Neutral rating and $109 price target. The analyst started the Rails sector with a Cautious coverage view and the Airfreight/Logistics sector with an Attractive coverage view. He believes uncertainty over NAFTA negotiations offset Kansas City Southern's "attractive growth story."
IR Ingersoll-Rand
$86.08

-2.91 (-3.27%)

03/21/18
JEFF
03/21/18
NO CHANGE
JEFF
Buy
Ingersoll-Rand removed from Franchise Picks List at Jefferies
Jefferies analyst Steve Volkmann removed Ingersoll-Rand (IR) from his firm's Franchise Picks List saying the margin story seems better known at current share levels. The analyst believes He believes Kennametal (KMT) "represents a more compelling self-help story and is earlier in the execution process." He keeps a Buy rating on Ingersoll-Rand.
03/21/18
JEFF
03/21/18
NO CHANGE
Target $60
JEFF
Buy
Kennametal added to Franchise Picks List at Jefferies
Jefferies analyst Steve Volkmann added Kennametal (KMT) to his firm's Franchise Picks List while removing Ingersoll-Rand (IR). The analyst believes Kennametal management can mitigate the impact to earnings from higher raw material costs, labor costs and production bottlenecks. He views the company as one of the most attractive self-help stories under his coverage. Volkmann keeps a Buy rating on Kennametal with a $60 price target.
02/15/18
LEHM
02/15/18
INITIATION
Target $111
LEHM
Overweight
Ingersoll-Rand initiated with an Overweight at Barclays
Barclays analyst Julian Mitchell started Ingersoll-Rand with an Overweight rating and $111 price target. The analyst initiated 24 Multi-Industry companies with a Neutral sector view.
02/02/18
BMOC
02/02/18
NO CHANGE
Target $115
BMOC
Outperform
Ingersoll-Rand price target raised to $115 from $105 at BMO Capital
BMO Capital analyst Joel Tiss raised his price target on Ingersoll-Rand to $115, saying the company's FY18 outlook calling for organic revenue growth of 3.0%-3.5% is conservative based on the management's expectations of volume growth and cost cuts. Tiss adds that the company has a history of reviving its brands, refreshing products, and reducing expenses to improve free cash flows over the past 5 years. The analyst keeps his Outperform rating on Ingersoll-Rand.
HON Honeywell
$146.88

-4.48 (-2.96%)

02/15/18
LEHM
02/15/18
INITIATION
Target $170
LEHM
Overweight
Honeywell initiated with an Overweight at Barclays
Barclays analyst Julian Mitchell started Honeywell with an Overweight rating and $170 price target. The analyst initiated 24 Multi-Industry companies with a Neutral sector view.
01/03/18
01/03/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Harley-Davidson (HOG) downgraded to Underperform from Neutral at Longbow with analyst David MacGregor saying channel checks in the fourth quarter revealed that Harley's U.S. retail sales are trending down 5%-7% with U.S. shipments expected to be down at least 20%. 2. TJX (TJX) downgraded to Market Perform from Outperform at Wells Fargo with analyst Ike Boruchow saying Marmaxx has simply become too big to generate share gains similar to years past. 3. Honeywell (HON) downgraded to Sector Perform from Outperform at RBC Capital with analyst Deane Dray saying the stock is likely to "take a breather" this year after a solid run in 2017, adding that despite the potential margin upside, the positive catalysts of "Turbo/Homes spin announcements and CEO transition" have played out. 4. Pinnacle West (PNW) downgraded to Underperform from Neutral at BofA/Merrill with analyst Julien Dumoulin-Smith saying valuation is priced at the "pinnacle" and sees risks that a -$1.3B CapEx budget still results in earnings closer to -5% on a net basis, and potential downside to Street estimates of between 5c-10c. 5. Charles Schwab (SCHW) downgraded to Market Perform from Outperform at JMP Securities with analyst Devin Ryan saying he now views its valuation as more adequately reflecting the current risk and reward following the stock's recent outperformance. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/22/18
UBSW
01/22/18
INITIATION
Target $182
UBSW
Buy
Honeywell initiated with a Buy at UBS
UBS initiated Honeywell with a Buy and $182 price target.
02/20/18
BARD
02/20/18
NO CHANGE
Target $187
BARD
Outperform
Honeywell weakness a buying opportunity, says Baird
Baird analyst Peter Arment sees positive momentum in 2018 for Honeywell and said he would take advantage of the recent pullback from its recent highs as a buying opportunity. Arment, who sees spinoffs and tax reform resulting in a higher valuation for the shares, reiterated his Outperform rating and $187 price target on Honeywell.
ROK Rockwell Automation
$175.96

-5.42 (-2.99%)

01/22/18
UBSW
01/22/18
INITIATION
Target $240
UBSW
Buy
Rockwell Automation initiated with a Buy at UBS
UBS initiated Rockwell with a Buy and $240 price target.
01/25/18
WELS
01/25/18
NO CHANGE
Target $200
WELS
Market Perform
Rockwell Automation price target raised to $200 from $190 at Wells Fargo
Wells Fargo analyst Rich Kwas raised his price target for Rockwell Automation to $200 from $190 following an "okay quarter." The analyst reiterates a Market Perform rating on the shares.
03/20/18
COWN
03/20/18
NO CHANGE
Target $175
COWN
Market Perform
Rockwell Automation price target raised to $175 from $165 at Cowen
Cowen analyst Joseph Giordano raised his price target on Rockwell Automation to $175 from $165, telling investors in a research note that the setup for the second half of the year looks "very challenging." The analyst said he believes numbers and broader positioning are "skewed too bullish" as macro data normalizes and comps ramp materially higher. While potential M&A and takeout risk help balance, and execution likely remains strong, he contended that expectations have "surpassed near-term operational reality." Giordano has a Market Perform rating on the shares.
02/15/18
LEHM
02/15/18
INITIATION
Target $200
LEHM
Equal Weight
Rockwell Automation initiated with an Equal Weight at Barclays
Barclays analyst Julian Mitchell started Rockwell Automation with an Equal Weight rating and $200 price target. The analyst initiated 24 Multi-Industry companies with a Neutral sector view.
KMT Kennametal
$41.50

-2.19 (-5.01%)

03/15/18
JEFF
03/15/18
NO CHANGE
Target $60
JEFF
Buy
Kennametal pullback brings 'compelling' entry point, says Jefferies
Despite "strong" earnings and raised guidance, Kennametal shares have traded off 8% relative to the S&P 500 year-to-date, Jefferies analyst Stephen Volkmann tells investors in a research note. The analyst sees a "compelling" entry point at current share levels. He believes Kennametal can mitigate the impact of higher material and labor costs to earnings through pricing and productivity initiatives. History suggests the company has pricing power, and labor increases are unlikely to be an issue, Volkmann contends. He recommends buying the shares on the recent pullback and keeps a Buy rating on the name with a $60 price target.
02/15/18
LEHM
02/15/18
INITIATION
Target $47
LEHM
Equal Weight
Kennametal initiated with an Equal Weight at Barclays
Barclays analyst Julian Mitchell started Kennametal with an Equal Weight rating and $47 price target. The analyst initiated 24 Multi-Industry companies with a Neutral sector view.
FTV Fortive
$76.69

-1.66 (-2.12%)

03/08/18
BARD
03/08/18
UPGRADE
Target $57
BARD
Outperform
Altra Industrial Motion upgraded to Outperform at Baird
As reported previously, Baird analyst Michael Halloran upgraded Altra Industrial Motion (AIMC) to Outperform from Neutral. The analyst believes 2018 will be a year of transformation following its deal with Fortive (FTV). The analyst said the deal synergies appear reasonable and the potential accretion will be significant. Halloran raised his price target to $57 from $50 on Altra Industrial shares.
03/08/18
SPHN
03/08/18
NO CHANGE
Target $52
SPHN
Overweight
Altra Industrial deal makes strategic sense, but raises risk, says Stephens
After Altra Industrial Motion (AIMC) announced an agreement to combine Altra with four operating companies from Fortive's (FTV) Automation and Specialty platform, Stephens analyst Matt Duncan said he likes the deal from a strategic standpoint and sees significant long-term earnings upside from the transaction. However, the deal increases the risk profile for Altra shareholders "a good bit" due to the high leverage at closing and "rich price tag." Duncan keeps an Overweight rating on Altra shares, but lowered his price target to $52 from $56 as he thinks the "short-term shift to the risk profile can't be ignored."
03/09/18
JPMS
03/09/18
DOWNGRADE
Target $84
JPMS
Neutral
Fortive downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Steve Tusa downgraded Fortive to Neutral with an $84 price target. The analyst believes the current valuation already reflects the company's upcoming capital deployment. He believes, however, that Fortive's "franchise quality remains intact."
02/15/18
LEHM
02/15/18
INITIATION
Target $86
LEHM
Overweight
Fortive initiated with an Overweight at Barclays
Barclays analyst Julian Mitchell started Fortive with an Overweight rating and $86 price target. The analyst initiated 24 Multi-Industry companies with a Neutral sector view.
MMM 3M
$223.17

-10.97 (-4.69%)

01/24/18
01/24/18
UPGRADE
Target $285

Buy
3M upgraded to Buy ahead of earnings at Hilliard Lyons
As previously reported, Hilliard Lyons analyst Spencer Joyce upgraded 3M to Buy from Neutral, saying he sees as a tactical opportunity ahead of its earnings report as he expects estimates to rise following the company's Q4 earnings release. He raised his 2018 and 2019 EPS estimates to $10.44 and $11.19, respectively, based on a lower effective tax rate and adjusting for current forex rates. Joyce has a $285 price target on 3M shares.
01/24/18
01/24/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. McKesson (MCK) upgraded to Buy from Hold at Jefferies analyst Brian Tanquilut saying the combination of stabilizing generic drug pricing, a discounted valuation relative to peers and higher earnings estimates due to tax reform will "boost investor interest this year and push the stock's multiple to more appropriate levels." 2. Cree (CREE) upgraded to Hold from Sell at Williams Capital. 3. 3M (MMM) upgraded to Buy from Neutral at Hilliard Lyons with analyst Spencer Joyce saying he sees as a tactical opportunity ahead of its earnings report as he expects estimates to rise following the company's fourth quarter earnings release. 4. Energen (EGN) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Evan Calio saying he expects oil markets to tighten and gas to remain weak in 2018. 5. Capital City Bank (CCBG) was upgraded to Outperform from Market Perform at Hovde Group and to Hold from Sell at Sandler O'Neill. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/15/18
LEHM
02/15/18
INITIATION
Target $235
LEHM
Underweight
3M initiated with an Underweight at Barclays
Barclays analyst Julian Mitchell started 3M with an Underweight rating and $235 price target. The analyst initiated 24 Multi-Industry companies with a Neutral sector view.
02/13/18
DBAB
02/13/18
UPGRADE
Target $275
DBAB
Buy
3M upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst John Inch upgraded 3M to Buy and raised his price target for the shares to $275 from $240. The company remains in the early innings of realizing cost-saving benefits from its reorganization, Inch tells investors in a research note. He expects the company's Business Transformation synergies to "meaningfully accelerate" beyond 2018. Further, after years of U.S. pricing headwinds, 3M could be on the cusp of realizing improved pricing trends, the analyst adds.
ALLE Allegion
$84.60

-1.34 (-1.56%)

02/15/18
LEHM
02/15/18
INITIATION
Target $100
LEHM
Overweight
Allegion initiated with an Overweight at Barclays
Barclays analyst Julian Mitchell started Allegion with an Overweight rating and $100 price target. The analyst initiated 24 Multi-Industry companies with a Neutral sector view.
02/21/18
IMPC
02/21/18
NO CHANGE
Target $94
IMPC
Outperform
Allegion price target raised to $94 from $85 at Imperial Capital
Imperial Capital analyst Jeff Kessler raised his price target for Allegion to $94 after management's fiscal 2018 outlook topped his previous estimates. The analyst maintains an Outperform rating on the shares.
10/30/17
WOLF
10/30/17
UPGRADE
WOLF
Outperform
Allegion upgraded to Outperform from Peer Perform at Wolfe Research
02/21/18
WELS
02/21/18
NO CHANGE
Target $105
WELS
Outperform
Allegion price target raised to $105 from $100 at Wells Fargo
Wells Fargo analyst Rich Kwas raised his price target for Allegion to $105 from $100 after a "nice rebound" quarter and as he feels good about 2018 growth outlook. The analyst reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

02:40
12/13/18
12/13
02:40
12/13/18
02:40
General news
FX Update: A risk-on theme has been coursing through forex markets »

FX Update: A risk-on…

01:45
12/13/18
12/13
01:45
12/13/18
01:45
General news
Asian Market Wrap: »

Asian Market Wrap:…

BHVN

Biohaven Pharmaceutical

$37.72

1.02 (2.78%)

20:51
12/12/18
12/12
20:51
12/12/18
20:51
Syndicate
Biohaven Pharmaceutical 3.3M share Secondary priced at $37.25 per share »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

FIVE

Five Below

$101.38

1.86 (1.87%)

20:48
12/12/18
12/12
20:48
12/12/18
20:48
Upgrade
Five Below rating change at Goldman Sachs »

Five Below upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRNS

Marinus Pharmaceuticals

$4.21

-0.89 (-17.45%)

20:28
12/12/18
12/12
20:28
12/12/18
20:28
Syndicate
Marinus Pharmaceuticals 12M share Secondary priced at $3.75 per share »

Jefferies and Leerink are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

UNM

Unum Group

$30.27

-0.04 (-0.13%)

20:25
12/12/18
12/12
20:25
12/12/18
20:25
Hot Stocks
Unum Group sees FY19 adjusted EPS growth of 4%-7% »

Sees FY19 tax rate of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

CIEN

Ciena

$32.14

0.535 (1.69%)

20:25
12/12/18
12/12
20:25
12/12/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

TDC

Teradata

$38.02

0.65 (1.74%)

20:18
12/12/18
12/12
20:18
12/12/18
20:18
Hot Stocks
Teradata targets 2021 recurring revenue growth of 14% »

Also sees 2021 gross…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 19

    Dec

  • 20

    Dec

HESM

Hess Midstream Partners

$19.43

0.38 (1.99%)

19:09
12/12/18
12/12
19:09
12/12/18
19:09
Hot Stocks
Hess Midstream Partners sees FY19 adjusted EBITDA $550M-$575M »

Sees FY19: net income…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOCA

Tocagen

$11.22

-1.63 (-12.68%)

19:05
12/12/18
12/12
19:05
12/12/18
19:05
Syndicate
Tocagen 3M share Secondary priced at $10.00 per share »

Citi and Leerink are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

ALL

Allstate

$82.37

-0.12 (-0.15%)

19:03
12/12/18
12/12
19:03
12/12/18
19:03
Hot Stocks
Allstate announces estimated November catastrophe losses of $685M »

Allstate announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$76.04

-0.64 (-0.83%)

19:01
12/12/18
12/12
19:01
12/12/18
19:01
Hot Stocks
Exxon makes final investment decision to develop West Barracouta gas project »

ExxonMobil said that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDSN

Nordson

$111.83

1.09 (0.98%)

, JCS

Communications Systems

$2.42

0.2 (9.01%)

19:00
12/12/18
12/12
19:00
12/12/18
19:00
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS:…

NDSN

Nordson

$111.83

1.09 (0.98%)

JCS

Communications Systems

$2.42

0.2 (9.01%)

BW

Babcock & Wilcox

$0.77

0.0569 (7.94%)

FIVE

Five Below

$101.38

1.86 (1.87%)

BABA

Alibaba

$151.49

-0.34 (-0.22%)

TLRD

Tailored Brands

$20.16

0.32 (1.61%)

LLNW

Limelight Networks

$3.20

0.025 (0.79%)

OXM

Oxford Industries

$74.88

0.895 (1.21%)

AGTC

Applied Genetic

$6.61

0.54 (8.90%)

VBIV

VBI Vaccines

$1.66

0.08 (5.06%)

HASI

Hannon Armstrong

$23.10

-0.16 (-0.69%)

BVN

Buenaventura

$15.25

0.22 (1.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 13

    Dec

  • 04

    Mar

  • 12

    Mar

  • 13

    Dec

  • 13

    Dec

OXM

Oxford Industries

$74.88

0.895 (1.21%)

18:58
12/12/18
12/12
18:58
12/12/18
18:58
Earnings
Oxford Industries cuts FY18 EPS view to $4.20-$4.35 from $4.45-$4.65 »

Cuts FY18 revenue view to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

OXM

Oxford Industries

$74.88

0.895 (1.21%)

18:56
12/12/18
12/12
18:56
12/12/18
18:56
Earnings
Oxford Industries sees Q4 EPS 96c-$1.11 vs. 93c last year »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

OXM

Oxford Industries

$74.88

0.895 (1.21%)

18:55
12/12/18
12/12
18:55
12/12/18
18:55
Earnings
Oxford Industries reports Q3 adjusted EPS 14c vs. 17c last year »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

NEXT

NextDecade

$4.74

0.04 (0.85%)

18:30
12/12/18
12/12
18:30
12/12/18
18:30
Hot Stocks
NextDecade's Rio Grande LNG project approved by TCEQ »

NextDecade Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$89.63

1.49 (1.69%)

18:15
12/12/18
12/12
18:15
12/12/18
18:15
Periodicals
United CEO seeks to boost flight network by 4%-6% next year, Reuters says »

United Airlines CEO Oscar…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

AKAO

Achaogen

$1.80

0.06 (3.45%)

17:58
12/12/18
12/12
17:58
12/12/18
17:58
Hot Stocks
Breaking Hot Stocks news story on Achaogen »

Robert Duggan raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLR

Fluor

$34.11

0.29 (0.86%)

17:56
12/12/18
12/12
17:56
12/12/18
17:56
Hot Stocks
Fluor announces participation in $2.1B rail project in Chicago »

Fluor announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIVE

Five Below

$101.38

1.86 (1.87%)

17:55
12/12/18
12/12
17:55
12/12/18
17:55
Upgrade
Five Below rating change at Goldman Sachs »

Five Below upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTC

Bitcoin

$0.00

(0.00%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

17:49
12/12/18
12/12
17:49
12/12/18
17:49
Hot Stocks
SEC says former execs behind allegedly fraudulent ICO settle scam charges »

Two former executives…

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PK

Park Hotels & Resorts

$29.28

0.08 (0.27%)

17:44
12/12/18
12/12
17:44
12/12/18
17:44
Hot Stocks
Park Hotels & Resorts announces Q4 dividend of $1.00 per share »

Park Hotels & Resorts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PK

Park Hotels & Resorts

$29.28

0.08 (0.27%)

17:44
12/12/18
12/12
17:44
12/12/18
17:44
Hot Stocks
Park Hotels & Resorts announces Q4 dividend of $1.00 per share »

Park Hotels & Resorts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNP

CenterPoint Energy

$28.90

0.12 (0.42%)

17:37
12/12/18
12/12
17:37
12/12/18
17:37
Hot Stocks
CenterPoint Energy raises dividend 4% to 28.75c per share »

The company's board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.